Enclomiphene

Enclomiphene is the trans-isomer of clomiphene and acts as a selective estrogen receptor modulator. In men with secondary hypogonadism, it can block estrogen feedback at the hypothalamus and pituitary, increasing luteinizing hormone (LH) and follicle-stimulating hormone (FSH). That can stimulate the testes to produce more of the body’s own testosterone rather than replacing testosterone from the outside. Randomized clinical research has shown that Enclomiphene can raise testosterone while maintaining sperm production better than topical testosterone therapy in studied men phase II trial.

Enclomiphene works by reducing estrogen’s negative feedback signal to the brain. That allows the hypothalamic-pituitary-gonadal axis to increase LH and FSH, which then signals the testes to produce testosterone and support sperm production. In randomized studies, Enclomiphene raised serum testosterone while preserving sperm counts, whereas topical testosterone suppressed gonadotropins and reduced spermatogenesis clinical trial. That makes Enclomiphene particularly relevant when the goal is to improve low-testosterone symptoms while maintaining endogenous testicular signaling. It is not appropriate for every cause of low testosterone, so baseline laboratory evaluation and diagnosis matter.

Enclomiphene should be prescribed with laboratory and clinical monitoring. Your clinician will first establish that your hormone pattern is appropriate for a medication that stimulates LH and FSH; primary testicular failure, untreated pituitary disease, fertility concerns, or other endocrine conditions may change the plan. Possible side effects can include headache, mood changes, visual symptoms, acne or oily skin, changes in estradiol, and symptoms associated with higher testosterone. Monitoring commonly includes testosterone and other hormone markers, with additional labs based on the patient’s age and risk factors.

Enclomiphene can begin raising testosterone within about 2 weeks. Changes in energy, libido, mood, or training recovery may take roughly 4–8 weeks, and laboratory response is commonly reassessed after several weeks of treatment. Symptoms and follow-up labs should be evaluated together because hormonal changes can occur before a patient feels a noticeable difference.

Bowery Clinic peptides are higher-strength and clinically dosed compared to most research facilities that use much lower concentrations. They are compounded by licensed 503A pharmacies with physician oversight and sterile quality standards, prioritizing real therapeutic outcomes over cheaper, unregulated research-grade products, and come fully prepared and ready for use — no mixing or reconstitution needed.

Yes. All pharmacies in our network are fully licensed in the states where they operate and comply with all state board of pharmacy regulations. Unlike many peptide clinics, we partner exclusively with FDA-registered U.S. pharmacies that undergo rigorous evaluation and compliance checks.

Every patient receives treatment plans developed and monitored by licensed providers. This includes safe titration of dosages and ongoing medical oversight tailored to individual needs.

Injections deliver the medication directly into your system. This makes the absorption more consistent and effective. Troches are small dissolvable lozenges that sit in your mouth until they melt, slowly releasing medication through the lining of your cheek or under your tongue.